Tarsus Pharmaceuticals has appointed David E. I. Pyott, former Chairman and CEO of Allergan and current director at several global healthcare companies, to its Board of Directors, where he will serve ...

David E. I. Pyott David E. I. Pyott, former Chairman and CEO of Allergan, Inc., was appointed to Tarsus Pharmaceuticals' Board of Directors. IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tarsus ...

David Pyott expected 2014 to be a year of hunting for deals. The tables were turned when Allergan Inc., the Irvine-based drugmaker he’s led for the past 16 years, became the hunted. “Normally, very ...

Talk about golden parachutes: Allergan’s Chief Executive Officer, David Pyott, could collect as much as $126 million after the company he’s run for the past 17 years is acquired by Ireland-based ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Sienna Biopharmaceuticals announced in a ...

The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company ...

David Pyott opened 2006 with a flourish. Allergan Inc., the Irvine-based drug maker he’s run for the past eight years, prevailed with a trumping $3.2 billion bid for Inamed Corp., a coveted maker of ...

Some stories end with happy-ever-after. Some endings are bitter sweet. When David Pyott became CEO of Allergan, the maker of Botox, he never imagined that his leading role would end as the latter.